Related Experiment Video
Updated: Jun 18, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
The RhoB p.S73F mutation leads to cerebral palsy through dysregulation of lipid homeostasis
Xinyu Wu1, Ruonan Liu1, Zhongtian Zhang2,3,4,5,6,7
1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, and College of Veterinary Medicine, Jilin University, Changchun, 130062, China.
Insights
A new rabbit model mimics human cerebral palsy (CP) caused by the RhoB p.S73F mutation. This genetic mutation alters lipid metabolism, leading to brain damage and CP symptoms.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Cerebral palsy (CP) is a major global health concern.
- A de novo mutation in RhoB (p.S73F) has been linked to CP.
- The underlying mechanism of RhoB-associated CP remains elusive.
Purpose of the Study:
- To establish a mammalian model for genetic CP.
- To elucidate the pathogenic mechanism of the RhoB p.S73F mutation.
- To identify potential therapeutic targets for CP.
Main Methods:
- Generated a rabbit model of the human RhoB p.S73F mutation using the SpG-BE4max system.
- Observed CP-like symptoms including periventricular leukomalacia and spastic-dystonic diplegia.
- Investigated the molecular pathways affected by the mutation.
Main Results:
- The rabbit model exhibited key features of human CP.
- RhoB p.S73F mutation activates ACAT1 via the LYN pathway.
- Altered lipid metabolism due to the mutation contributes to neuronal and white matter damage.
Conclusions:
- This study presents the first mammalian model for RhoB-related genetic CP.
- Provides insights into the link between RhoB, lipid metabolism, and CP.
- Identifies novel therapeutic targets for CP treatment.
Abstract:
Cerebral palsy (CP) is a prevalent neurological disorder that imposes a significant burden on children, families, and society worldwide. Recently, the RhoB p.S73F mutation was identified as a de novo mutation associated with CP. However, the mechanism by which the RhoB p.S73F mutation causes CP is currently unclear. In this study, rabbit models were generated to mimic the human RhoB p.S73F mutation using the SpG-BE4max system, and exhibited the typical symptoms of human CP, such as periventricular leukomalacia and spastic-dystonic diplegia. Further investigation revealed that the RhoB p.S73F mutation could activate ACAT1 through the LYN pathway, and the subsequently altered lipid levels may lead to neuronal and white matter damage resulting in the development of CP. This study presented the first mammalian model of genetic CP that accurately replicates the RhoB p.S73F mutation in humans, provided further insights between RhoB and lipid metabolism, and novel therapeutic targets for human CP.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Abnormal Proliferation
Pleiotropy

